KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Other Operating Expenses: 2009-2025

Historic Other Operating Expenses for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $6.5 billion.

  • Thermo Fisher Scientific's Other Operating Expenses rose 4.29% to $6.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 billion, marking a year-over-year increase of 2.36%. This contributed to the annual value of $25.2 billion for FY2024, which is 2.25% down from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Other Operating Expenses stood at $6.5 billion, which was up 1.43% from $6.4 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Other Operating Expenses' 5-year high stood at $6.8 billion during Q4 2022, with a 5-year trough of $4.7 billion in Q4 2021.
  • Over the past 3 years, Thermo Fisher Scientific's median Other Operating Expenses value was $6.4 billion (recorded in 2023), while the average stood at $6.4 billion.
  • In the last 5 years, Thermo Fisher Scientific's Other Operating Expenses surged by 36.25% in 2022 and then dropped by 6.56% in 2024.
  • Over the past 5 years, Thermo Fisher Scientific's Other Operating Expenses (Quarterly) stood at $5.4 billion in 2021, then grew by 25.62% to $6.8 billion in 2022, then fell by 5.13% to $6.5 billion in 2023, then climbed by 1.25% to $6.6 billion in 2024, then rose by 4.29% to $6.5 billion in 2025.
  • Its Other Operating Expenses stands at $6.5 billion for Q3 2025, versus $6.4 billion for Q2 2025 and $6.1 billion for Q1 2025.